Nisa Leung is a Partner of Qiming Ventures leading its health care investments. Qiming is one of the most active funds in China and have won numerous awards including most recently The Best Venture Firm in China at Top Capital Summit in 2011, 2011 Top 10 China VC Funds by Zero2Ipo and Best Health Care Investment Firm in China in 2011.
William is a Partner of Qiming Ventures, focusing on the investment in healthcare & life science sector. He has over 13 years of investing, strategy consulting, and operating experience in healthcare sector. Prior to joining Qiming, he was the director with CITIC Future Investment, strategy consultant with IBM BCS, and product manager with Colorcon. William currently is board director of Tigermed (SZ: 300347), Coland Pharma (TW: 4144), Sangon Bio, Arrail Dental, Centreherbs Bio, Tellgen Lifescience, Guokang Healthcare, and other several medical device & diagnostics reagents developers.
Yong Zhang is a Cleantech Practice Partner of Qiming Venture Partners. Prior to joining Qiming, Yong was the China Technology Growth Leader of General Electric company, responsible for managing the $30 million in China for China fund and driving the overall company external technology BD and collaboration.
Janet Yu joined Qiming in 2009，focusing on the RMB fund raising and government relation. She has over 10 years of managing, operating, founding and investing experience. Prior to Qiming, she was the general manager of fund investing department in China Binhai New Area Venture Capital Guiding Fund, in charge of fund investment.
Steven joined Qiming in 2009. He has 10 years work & management experiences in internet& wireless industry. He has start-up or early-stage experiences in 3 NASDAQ listed companies--KongZhong Corp, Sohu.com and Sina.com.
